Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 2228 of 2228 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/01/23
End: 06/14/24
Due: 06/14/25
Phase: N/A
Priority: Normal
Start: 03/20/18
End: 10/07/19
Due: 10/07/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma | NCT01122680 | Boehringer Ingelheim | user2@example.com | None | 2010-05-31 | - | - | - | - | 2025-07-14 |
| A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood | NCT05738291 | Boehringer Ingelheim | user2@example.com | None | 2023-05-01 | 2024-06-14 | 2025-06-14 | - | - | 2025-07-14 |
| This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms | NCT03448419 | Boehringer Ingelheim | user2@example.com | None | 2018-03-20 | 2019-10-07 | 2020-10-07 | - | - | 2025-07-14 |